BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 19407437)

  • 1. Partial reconstitution of cutaneous microvessels in long-term survivors after allogeneic bone marrow transplantation.
    Haeusermann P; Kump E; Rovó A; Tichelli A; Itin P; Gratwohl A; Biedermann BC
    Dermatology; 2009; 219(1):32-41. PubMed ID: 19407437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
    Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
    Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penile lichen sclerosus after allogeneic stem cell transplantation.
    Au WY; Yeung CK; Cheung MC; Trendell-Smith NJ
    Br J Dermatol; 2008 Aug; 159(2):470-2. PubMed ID: 18503592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing face of graft-versus-host disease.
    Schaffer JV
    Semin Cutan Med Surg; 2006 Dec; 25(4):190-200. PubMed ID: 17174839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous lichenoid graft-versus-host disease mimicking lupus erythematosus.
    Goiriz R; Peñas PF; Delgado-Jiménez Y; Fernández-Herrera J; Aragüés-Montañés M; Fraga J; García-Díez A
    Lupus; 2008 Jun; 17(6):591-5. PubMed ID: 18539715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of chronic cutaneous graft-versus-host disease in Japanese leukemia patients after bone marrow transplantation: low incidence and mild manifestations of skin lesions.
    Fujii H; Hiketa T; Matsumoto Y; Ohashi M; Miyamura Y; Tanimoto M; Morishima Y; Saito H; Horibe K; Shibata Y
    Bone Marrow Transplant; 1992 Oct; 10(4):331-5. PubMed ID: 1422488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
    Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin.
    Wetzig T; Sticherling M; Simon JC; Hegenbart U; Niederwieser D; Al-Ali HK
    Bone Marrow Transplant; 2005 Mar; 35(5):515-9. PubMed ID: 15665847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isomorphic cutaneous graft-versus-host disease reaction after ultraviolet exposure: clinical, histological and direct immunofluorescence studies of four allo-transplanted patients.
    Vassallo C; Brazzelli V; Zecca M; Locatelli F; Alessandrino PE; Borroni G
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):913-8. PubMed ID: 19586515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome.
    Skert C; Patriarca F; Sperotto A; Cerno M; Filì C; Zaja F; Stocchi R; Geromin A; Damiani D; Fanin R
    Haematologica; 2006 Feb; 91(2):258-61. PubMed ID: 16461315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic cutaneous graft-versus-host disease in man.
    Shulman HM; Sale GE; Lerner KG; Barker EA; Weiden PL; Sullivan K; Gallucci B; Thomas ED; Storb R
    Am J Pathol; 1978 Jun; 91(3):545-70. PubMed ID: 26221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narrowband ultraviolet B phototherapy in the treatment of cutaneous graft-versus-host disease in oncohaematological paediatric patients.
    Brazzelli V; Grasso V; Muzio F; Moggio E; Zecca M; Locatelli F; Borroni G
    Br J Dermatol; 2010 Feb; 162(2):404-9. PubMed ID: 19903177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered functional status of the hypothalamic dopaminergic tone in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a pilot study.
    Parra A; Ramírez-Peredo J; Hidalgo R; Morales-Toquero A; Velásquez-Ramírez G; Ruiz-Argüelles A; Ruiz-Argüelles GJ
    Biol Blood Marrow Transplant; 2006 May; 12(5):566-72. PubMed ID: 16635792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in FOXP3+ regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response.
    Fondi C; Nozzoli C; Benemei S; Baroni G; Saccardi R; Guidi S; Nicoletti P; Bartolozzi B; Pimpinelli N; Santucci M; Bosi A; Massi D
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):938-47. PubMed ID: 19589483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow.
    Heldal D; Brinch L; Evensen SA; Tjønnfjord GE; Aamodt G; Elgjo K; Sviland L
    Bone Marrow Transplant; 2004 Aug; 34(4):345-50. PubMed ID: 15170163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease.
    Deguchi M; Aiba S; Ohtani H; Nagura H; Tagami H
    Arch Dermatol Res; 2002 Oct; 294(7):297-302. PubMed ID: 12373334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PUVA therapy for chronic cutaneous graft-vs-host disease.
    Jampel RM; Farmer ER; Vogelsang GB; Wingard J; Santos GW; Morison WL
    Arch Dermatol; 1991 Nov; 127(11):1673-8. PubMed ID: 1952971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis.
    Firoz BF; Lee SJ; Nghiem P; Qureshi AA
    Arch Dermatol; 2006 Feb; 142(2):175-82. PubMed ID: 16490845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.